A new article
Day-to-day care
1 supporting source
confidence 97%
novelty 75%
Treatment Options for Patients with Maturity-Onset Diabetes of the Young (MODY): A Systematic Review of Literature: 2026 Update
Treatment Options for Patients with Maturity-Onset Diabetes of the Young (MODY): A Systematic Review of Literature: 2026 Update INTRODUCTION: Maturity-onset diabetes of the young (MODY) is a rare monogenic form of diabetes characterized by impaired insulin secretion and genetic and clinical heterogeneity.
How this was derived
Indexed from **openalex** on 2026-11-13 (relevance 0.56, tier peer_reviewed).
Generated 2026-11-13, last changed
yesterday. Dedup key newdoc:549.
The engine re-checks this insight on every analysis run; if more sources agree, its corroboration and confidence go up and it reappears as “new”.
Evidence (1 quote)
Treatment Options for Patients with Maturity-Onset Diabetes of the Young (MODY): A Systematic Review of Literature: 2026 Update
peer_reviewed
· published 2026-06-15
· live page
Glucokinase (GCK)-MODY remains managed without pharmacological treatment outside pregnancy, but dorzagliatin, a novel agent acting as a glucokinase activator, may further expand precision treatment approaches.
Supporting documents (1)
| Story | Source | Published | Seen | Relevance |
|---|---|---|---|---|
| Treatment Options for Patients with Maturity-Onset Diabetes of the ... | openalex | 2026-06-15 | yesterday | 0.56 |